Technology based guided meditation and relaxation for Delirium

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
DeliriumTechnology based guided meditation and relaxation - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether an immersive digital reality system can help reduce the occurrence of delirium in ICU patients.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 6 Secondary · Reporting Duration: Daily up to 14 days

Day 14
DREAMS usability and acceptability questionnaire
Day 14
Subject's quality of sleep
Day 7
Amount of sedatives requested by subjects
Amount of sedatives subjects receive
Respiratory Rate
Day 7
Assessment of anxiety measured by Hospital Anxiety and Depression Scale (HADS) questionnaire
Day 7
Blood Pressure -Systolic
Heart Rate
Patient pain perception

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Mediation and Relaxation Intervention
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Technology based guided meditation and relaxation · No Placebo Group · N/A

Mediation and Relaxation Intervention
Device
Experimental Group · 1 Intervention: Technology based guided meditation and relaxation · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: daily up to 14 days

Who is running the clinical trial?

University of FloridaLead Sponsor
1,249 Previous Clinical Trials
698,593 Total Patients Enrolled
5 Trials studying Delirium
722 Patients Enrolled for Delirium
Azra Bihorac, MDPrincipal InvestigatorUniversity of Florida
5 Previous Clinical Trials
828 Total Patients Enrolled
2 Trials studying Delirium
330 Patients Enrolled for Delirium

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: